rabeprazole has been researched along with ilaprazole in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 7 (63.64) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, EH; Kim, HY; Lee, SK; Park, CH; Roh, YH | 1 |
| Baik, GH; Bang, CS; Choi, MH; Jang, HJ; Kae, SH; Kim, HY; Park, SW; Seo, SI; Shin, SP; Shin, WG; Yang, YJ | 1 |
| Fan, L; Haitang, H; Jielai, X; Ling, W; Xianghong, Q; Ying, H | 1 |
| Kan, LD; Li, LC; Wu, CY; Ying, J; Yu, ZW | 1 |
| Hou, X; Ji, Q; Jiang, X; Jin, Z; Li, C; Li, Q; Long, H; Qiu, W; Shen, T; Wang, W; You, J | 1 |
| Arnaud, B; Arnoult, C; Escoffier, J; Hograindleur, JP; Kaba, M; Le Blévec, E; Martinez, G; Nef, S; Ray, PF; Stévant, I | 1 |
| Chen, F; Fang, B; He, X; Wang, S | 1 |
| Bhaduri-McIntosh, S; Bleck, CKE; Carter, C; Mannemuddhu, SS; Tjandra, N; Xu, H | 1 |
| Cui, Y; Han, Z; Hou, X; Jiang, X; Jin, Z; Li, C; Li, Q; Qiu, W; Shen, T; You, J | 1 |
| Cheng, X; Han, T; Jin, R; Li, J; Li, K | 1 |
| Chen, J; Deng, W; Xie, Z; Yang, S | 1 |
2 review(s) available for rabeprazole and ilaprazole
| Article | Year |
|---|---|
The association between the use of proton pump inhibitors and the risk of hypomagnesemia: a systematic review and meta-analysis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Dexlansoprazole; Esomeprazole; Humans; Lansoprazole; Magnesium; Odds Ratio; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Risk Factors; Treatment Outcome | 2014 |
Efficacy and safety of proton pump inhibitors versus vonoprazan in treatment of erosive esophagitis: A PRISMA-compliant systematic review and network meta-analysis.
Topics: Abdominal Injuries; Esomeprazole; Esophagitis, Peptic; Humans; Network Meta-Analysis; Peptic Ulcer; Proton Pump Inhibitors; Rabeprazole | 2022 |
2 trial(s) available for rabeprazole and ilaprazole
| Article | Year |
|---|---|
Effect of ilaprazole on the healing of endoscopic submucosal dissection-induced gastric ulcer: randomized-controlled, multicenter study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Endoscopic Mucosal Resection; Female; Humans; Male; Middle Aged; Postoperative Complications; Prospective Studies; Proton Pump Inhibitors; Rabeprazole; Stomach Neoplasms; Stomach Ulcer; Wound Healing | 2019 |
Ilaprazole Compared With Rabeprazole in the Treatment of Duodenal Ulcer: A Randomized, Double-blind, Active-controlled, Multicenter Study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Dose-Response Relationship, Drug; Double-Blind Method; Duodenal Ulcer; Female; Humans; Male; Middle Aged; Proton Pump Inhibitors; Rabeprazole | 2019 |
7 other study(ies) available for rabeprazole and ilaprazole
| Article | Year |
|---|---|
The status of proton pump inhibitor use: a prescription survey of 45 hospitals in China.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; China; Comorbidity; Esomeprazole; Female; Health Care Surveys; Hospitals; Humans; Inappropriate Prescribing; Lansoprazole; Male; Middle Aged; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Young Adult | 2019 |
The study of intestinal absorption and biodistribution in vivo of proton pump inhibitors.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Intravenous; Administration, Oral; Animals; Drug Stability; Female; Intestinal Absorption; Male; Proton Pump Inhibitors; Rabeprazole; Rats; Rats, Sprague-Dawley; Sex Factors; Temperature; Tissue Distribution | 2020 |
Pantoprazole, a proton-pump inhibitor, impairs human sperm motility and capacitation in vitro.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Fertilization; Humans; Lansoprazole; Male; Membrane Potentials; Middle Aged; Omeprazole; Pantoprazole; Phosphorylation; Proton Pump Inhibitors; Rabeprazole; Retrospective Studies; Semen Analysis; Sperm Capacitation; Sperm Maturation; Sperm Motility; Spermatozoa; Young Adult | 2020 |
Simultaneous Quantitative Analysis of Six Proton-Pump Inhibitors with a Single Marker and Evaluation of Stability of Investigated Drugs in Polypropylene Syringes for Continuous Infusion Use.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Chromatography, High Pressure Liquid; Drugs, Investigational; Esomeprazole; Humans; Lansoprazole; Molecular Structure; Omeprazole; Pantoprazole; Polypropylenes; Proton Pump Inhibitors; Rabeprazole | 2020 |
Prazoles Targeting Tsg101 Inhibit Release of Epstein-Barr Virus following Reactivation from Latency.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; A549 Cells; Antiviral Agents; Cell Line, Tumor; DNA-Binding Proteins; Endosomal Sorting Complexes Required for Transport; Epstein-Barr Virus Infections; HEK293 Cells; Herpesvirus 4, Human; Humans; Proton Pump Inhibitors; Rabeprazole; Transcription Factors; Viral Load; Virus Activation; Virus Latency; Virus Release; Virus Replication | 2021 |
An analysis of the biopharmaceutical behaviour of proton pump inhibitors with different physicochemical properties.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Absorption, Physicochemical; Adsorption; Animals; Biological Products; Chemical Phenomena; China; Esomeprazole; Female; Ileum; Intestinal Absorption; Jejunum; Male; Proton Pump Inhibitors; Rabeprazole; Rats; Rats, Sprague-Dawley; Tandem Mass Spectrometry; Tissue Distribution | 2021 |
The influence of different proton pump inhibitors and potassium-competitive acid blockers on indomethacin-induced small intestinal injury.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Inflammatory Agents, Non-Steroidal; DNA, Ribosomal; Indomethacin; Intestinal Diseases; Intestinal Mucosa; Intestine, Small; Lipopolysaccharides; Mice; Omeprazole; Potassium; Proton Pump Inhibitors; Pyrroles; Rabeprazole; Sulfonamides | 2022 |